Patent 12059671 was granted and assigned to Cresco Labs on August, 2024 by the United States Patent and Trademark Office.
A cannabis oil formulation comprises a level of terpene concentration of at least 4.88% by weight, detectable levels of tetrahydrocannabinol (THC) and at least two other cannabinoids, and a level of tetrahydrocannabinolic acid (THCA) concentration that is not detectable.